Ioannis Papageorgiou

Overview

Explore the profile of Ioannis Papageorgiou including associated specialties, affiliations and a list of published articles.

Snapshot

Articles 23

Citations 316

Followers 0

Related Specialties

Pharmacology

Biochemistry

Oncology

Top 10 Co-Authors

Michael H Court

Aris Antsaklis

Jatinder K Lamba

George Diallinas

Rolf Symons

Juvianee I Estrada-Veras

Ioannis Katsoulis

Ashkan A Malayeri

Moozhan Nikpanah

Michael R Loken

Published In

Biochem Pharmacol

J Mol Biol

Eur Radiol

Drug Metab Dispos

J Magn Reson Imaging

Affiliations

Soon will be listed here.

Recent Articles

Segmented 3D Echo Planar Acquisition for Rapid Susceptibility-Weighted Imaging: Application to Microhemorrhage Detection in Traumatic Brain Injury

Wang W, Li N, Papageorgiou I, Chan L, Pham D, Butman J

J Magn Reson Imaging . 2022 Jul; 56(5):1529-1535. PMID: 35852491

Background: Susceptibility-weighted imaging (SWI) provides superior image contrast of cerebral microhemorrhages (CMBs). It is based on a three-dimensional (3D) gradient echo (GRE) sequence with a relatively long imaging time. Purpose:...

Lung-Targeted Delivery of Dimethyl Fumarate Promotes the Reversal of Age-Dependent Established Lung Fibrosis

Kato K, Papageorgiou I, Shin Y, Kleinhenz J, Palumbo S, Hahn S, et al.

Antioxidants (Basel) . 2022 Mar; 11(3). PMID: 35326142

Idiopathic pulmonary fibrosis (IPF), a severe and deadly form of lung fibrosis, is widely regarded as a disease of aging. We previously demonstrated that aged mice with persistent lung fibrosis...

Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing

Kato K, Shin Y, Palumbo S, Papageorgiou I, Hahn S, Irish J, et al.

Eur Respir J . 2021 Sep; 58(5). PMID: 34531276

No abstract available.

Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoforms

Gbadamosi M, Shastri V, Hylkema T, Papageorgiou I, Pardo L, Cogle C, et al.

Future Oncol . 2020 Dec; 17(3):263-277. PMID: 33356566

The aim of this study was to establish the therapeutic relevance of the CD33 isoform by developing novel antibodies targeting the IgC domain of CD33. Two novel IgC-targeting antibodies, HL2541...

Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin

Short N, Richard-Carpentier G, Kanagal-Shamanna R, Patel K, Konopleva M, Papageorgiou I, et al.

Am J Hematol . 2020 May; 95(9):E225-E228. PMID: 32356320

No abstract available.

Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization

Martinez S, Andresen M, Zhu Z, Papageorgiou I, Court M

Sci Rep . 2020 Jan; 10(1):69. PMID: 31919457

Greyhounds recover more slowly from certain injectable anesthetics than other dog breeds. Previous studies implicate cytochrome P450 (CYP) 2B11 as an important clearance mechanism for these drugs and suggest Greyhounds...

CCGG deletion (rs201074739) in CD33 results in premature termination codon and complete loss of CD33 expression: another key variant with potential impact on response to CD33-directed agents

Papageorgiou I, Loken M, Brodersen L, Gbadamosi M, Uy G, Meshinchi S, et al.

Leuk Lymphoma . 2019 Feb; 60(9):2287-2290. PMID: 30721105

No abstract available.

Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAF mutation

Mirmomen S, Sirajuddin A, Nikpanah M, Symons R, Paschall A, Papageorgiou I, et al.

Eur Radiol . 2018 May; 28(11):4635-4642. PMID: 29736852

Objectives: To investigate the computed tomography (CT) thoracic findings in Erdheim-Chester disease (ECD) and evaluate the association of these findings with the BRAF mutation. Methods: This was a prospective study...

Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAF mutation

Nikpanah M, Kim L, Mirmomen S, Symons R, Papageorgiou I, Gahl W, et al.

Eur Radiol . 2018 Mar; 28(9):3751-3759. PMID: 29556768

Objectives: To use magnetic resonance imaging (MRI) and computed tomography (CT) to define abdominal involvement in Erdheim-Chester disease (ECD), and to investigate the association between these findings and the BRAF...

10.

Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach

Papageorgiou I, Court M

Biochem Pharmacol . 2017 Oct; 146:199-213. PMID: 28962835

Posttranscriptional repression of UDP-glucuronosyltransferase (UGT) 2B7 and 2B15 expression by microRNAs (miRNAs) may be an important mechanism underlying inter-individual variability in drug glucuronidation. Furthermore, the UGT2B15 3'-UTR contains a common...